Lynch L, Hogan AE, Duquette D, Lester C, Banks A, LeClair K, et al
Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose
longer-term data will follow
Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B
Insurance coverage decisions typically require demonstration of obesity through BMI thresholds with or without metabolic comorbidities but do not specifically require established cardiovascular disease
These medications have become popular in recent years as a treatment for type 2 diabetes due to their ability to reduce appetite, promote weight optimization, and improve glycemic control